Amer Al-Mazrou

Learn More
Accumulating evidence supports cancer to initiate and develop from a small population of stem-like cells termed as cancer stem cells (CSC). The exact phenotype of CSC and their counterparts in normal mammary gland is not well characterized. In this study our aim was to evaluate the phenotype and function of stem/progenitor cells in normal mammary epithelial(More)
Mesenchymal stem cells have properties that make them amenable to therapeutic use. However, the acceptance of mesenchymal stem cells in clinical practice requires standardized techniques for their specific isolation. To date, there are no conclusive marker (s) for the exclusive isolation of mesenchymal stem cells. Our aim was to identify markers(More)
Triple-negative breast cancer (TNBC) is an aggressive histological subtype with limited treatment options and very poor prognosis following progression after standard chemotherapeutic regimens. Therefore, novel molecules and therapeutic options are urgently needed for this category of patients. Recently, we have identified PAC as a curcumin analogue with(More)
  • Citation Wetzig, A Alaiya, M Al-Alwan, C B Pradez, M S Pulicat, A Al-Mazrou +14 others
  • 2013
The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters. et al. 2013. " Differential marker expression by cultures rich in mesenchymal stem cells. " BMC Abstract Background: Mesenchymal stem cells have properties that make them amenable to therapeutic use. However, the acceptance of(More)
  • 1